Chemical Component Summary | |
---|---|
Name | N-OMEGA-NITRO-L-ARGININE |
Synonyms | NNA |
Identifiers | (2S)-2-amino-5-[(N-nitrocarbamimidoyl)amino]pentanoic acid |
Formula | C6 H13 N5 O4 |
Molecular Weight | 219.199 |
Type | L-PEPTIDE LINKING |
Isomeric SMILES | [H]/N=C(\NCCC[C@@H](C(=O)O)N)/N[N+](=O)[O-] |
InChI | InChI=1S/C6H13N5O4/c7-4(5(12)13)2-1-3-9-6(8)10-11(14)15/h4H,1-3,7H2,(H,12,13)(H3,8,9,10)/t4-/m0/s1 |
InChIKey | MRAUNPAHJZDYCK-BYPYZUCNSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 28 |
Chiral Atom Count | 1 |
Bond Count | 27 |
Aromatic Bond Count | 0 |
Drug Info: DrugBank
DrugBank ID | DB04223 |
---|---|
Name | Nitroarginine |
Groups |
|
Description | An inhibitor of nitric oxide synthetase which has been shown to prevent glutamate toxicity. Nitroarginine has been experimentally tested for its ability to prevent ammonia toxicity and ammonia-induced alterations in brain energy and ammonia metabolites. (Neurochem Res 1995:200(4):451-6) |
Synonyms |
|
Categories |
|
CAS number | 2149-70-4 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Nitric oxide synthase, endothelial | MGNLKSVAQEPGPPCGLGLGLGLGLCGKQGPATPAPEPSRAPASLLPPAP... | unknown | |
Nitric oxide synthase, brain | MEDHMFGVQQIQPNVISVRLFKRKVGGLGFLVKERVSKPPVIISDLIRGG... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL227744 |
PubChem | 28360916, 440005, 135409365, 135453301 |
ChEMBL | CHEMBL227744 |
ChEBI | CHEBI:27960 |